Good morning, everyone, and welcome to another working week. We hope the weekend respite was somehow relaxing and invigorating, because that oh-so predictable routine of Zoom meetings, Skype calls, and deadlines has returned. But what can you do? The world, after all, keeps on spinning. So please join us while we give it a push and brew a delicious cup of stimulation. Our choice today is caramel vanilla cream. Meanwhile, here are a few tidbits to help you start the day. We hope all goes well and you remain safe. …

Nearly a dozen children’s hospitals in the U.S. are forming a coalition aimed at blunting unstable medicine supplies, turning to Phlow, a company that grew out of the Covid-19 pandemic, Bloomberg News notes. Early on, the Children’s Hospital Coalition, which officially kicked off its work last month, expects to focus on pain medications, sedatives, nutrition management, and blood pressure maintenance. Last May, Phlow was awarded $354 million by the Trump administration to help produce Covid-19 treatments made in the U.S.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What’s included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.


Leave a Reply

ArabicChinese (Simplified)EnglishFrenchGermanItalianJapanesePortugueseRussianSpanish

[mc4wp_form id="449"]